onem-20210901
0001404123FALSE00014041232021-06-032021-06-0300014041232021-05-122021-05-12

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549 
__________________________  
FORM 8-K 
__________________________ 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 1, 2021
__________________________  
1LIFE HEALTHCARE, INC.
(Exact name of Registrant as Specified in Its Charter)
__________________________ 
 
 
Delaware001-3920376-0707204
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
One Embarcadero Center, Suite 1900
San Francisco, CA 94111
(415) 814-0927
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
__________________________  
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading
Symbol(s)
 Name of each exchange
on which registered
Common Stock, $0.001 par value ONEM The Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  



Item 2.01. Completion of Acquisition or Disposition of Assets.

On September 1, 2021, 1Life Healthcare, Inc., a Delaware corporation (“One Medical”), completed its previously announced acquisition of Iora Health, Inc., a Delaware corporation (“Iora”), as contemplated by that certain Agreement and Plan of Merger, dated as of June 6, 2021, (the “Merger Agreement”), by and among One Medical, SB Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of One Medical (“Merger Sub”), Iora, and Fortis Advisors LLC, a Delaware limited liability company, solely in its capacity as the representative of the stockholders of Iora, pursuant to which Merger Sub merged with and into Iora (the “Merger”), with Iora surviving the Merger as a wholly-owned subsidiary of One Medical.

Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the “Effective Time”), each share of Iora capital stock (“Iora Capital Stock”) that was issued and outstanding immediately prior to the Effective Time (other than dissenting shares, shares of treasury stock and any shares of Iora Capital Stock owned by One Medical or any affiliated entity of One Medical) was cancelled and automatically converted into the right to receive approximately 0.690 shares (the “Exchange Ratio”) of One Medical common stock (“One Medical Common Stock”) and, if applicable, an amount in cash, without interest, rounded to the nearest whole cent, in lieu of any fractional share interest in One Medical Common Stock to which such holder otherwise would have been entitled. The total number of shares of One Medical Common Stock issued or reserved for issuance was approximately 56.1 million shares (the “Merger Shares”). 779,153 of the Merger Shares are held in an escrow fund for purposes of satisfying any post-closing purchase price adjustments and indemnification claims under the Merger Agreement.

At the Effective Time, each Iora stock option that was outstanding as of immediately prior to the Effective Time was automatically converted into a One Medical stock option with respect to One Medical Common Stock, with the number of shares underlying, and with the exercise price applicable to, such converted stock option adjusted based on the Exchange Ratio to preserve its intrinsic value (the “Rollover Options”). Each Iora phantom stock award that was outstanding and vested as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash calculated based on the merger consideration value. Each other Iora phantom stock award that was outstanding as of immediately prior to the Effective Time was assumed and converted into the right to receive an amount in cash calculated based on the merger consideration value, which resulting cash award will generally remain subject to the same terms and conditions as applied prior to the Effective Time but will be paid to the holder on its time-based vesting schedule. Each Iora warrant that was unexpired, unexercised and outstanding as of the Effective Time was cancelled.

The issuance of the outstanding Merger Shares was registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to a registration statement on Form S-4 (File No. 333-257720), as amended, filed by One Medical with the Securities and Exchange Commission (the “SEC”) and declared effective on July 16, 2021 (the “Registration Statement”). One Medical intends to file a registration statement on Form S-8 following the Effective Time to register under the Securities Act the issuance of Merger Shares underlying the Rollover Options.

The foregoing description of the Merger and the Merger Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement, a copy of which was filed as Exhibit 2.1 to the Registration Statement.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

At the Effective Time, Mary Ann Tocio, a director of Iora prior to the Merger, was appointed by the board of directors of One Medical (the “Board”) to serve as a Class III director, with an initial term expiring at One Medical’s 2023 Annual Meeting of Stockholders. Ms. Tocio was also appointed to serve as a member of the Nominating and Corporate Governance Committee of the Board.

Ms. Tocio served as President and Chief Operating Officer of Bright Horizons Family Solutions, Inc., an employer-sponsored child care provider (“Bright Horizons”), from June 2000 until her retirement in June 2015. From January 1992 to May 2000, Ms. Tocio held several executive positions at Bright Horizons, including as Chief Operating Officer and Vice President and General Manager of Child Care Operations. Prior to Bright Horizons, Ms. Tocio was the Senior Vice President of Operations for Health Stop Medical Management, Inc., a provider of urgent care services. Ms. Tocio currently serves as a member of the board of directors of Bright Horizons, Burlington Stores, Inc., a national off-price retailer, and previously served on the board of Civitas Solutions, Inc. (The MENTOR Network), a provider of health and human services, from October 2015 to March 2019, and the board of Mac-Gray Corporation, a laundry services company, from November 2006 to June 2013. Ms. Tocio holds a Master of Business Administration from Simmons College School of Management and graduated from Lawrence Memorial School of Nursing. One Medical believes that Ms. Tocio is qualified to serve on the Board based on her leadership and multi-site operational experience and substantial public company board experience.

Ms. Tocio was designated by Iora to be appointed to One Medical’s Board at the Effective Time pursuant to the terms of the Merger Agreement. There are no other arrangements or understandings between Ms. Tocio and any other persons pursuant to which she was selected as a director of One Medical. There is no transaction involving Ms. Tocio that requires disclosure under



Item 404(a) of Regulation S-K. The Board has determined that Ms. Tocio is independent under its Corporate Governance Guidelines and the listing standards of the Nasdaq Stock Market LLC.

Ms. Tocio will participate in One Medical’s Non-Employee Director Compensation Policy (the “Policy”), which is described in One Medical’s Definitive Proxy Statement on Schedule 14A for its 2021 Annual Meeting of Stockholders, filed with the SEC on April 21, 2021. Under the Policy, Ms. Tocio will be eligible to receive (i) an annual retainer of $50,000 for her service on the Board, with payment pro-rated to her start date of September 1, 2021, (ii) an initial restricted stock unit grant having a value of $247,500, which will vest annually over three years, commencing on September 1, 2021, subject to Ms. Tocio’s continuous service as a member of the Board, and (iii) an additional restricted stock unit grant on the date of each future annual meeting of our stockholders having a value of $165,000, which will vest on the earlier of the date of the following annual meeting of stockholders and the one-year anniversary of the grant date, subject to Ms. Tocio’s continuous service as a member of the Board.

At the Effective Time, One Medical also entered into its standard form of indemnification agreement with Ms. Tocio.

Item 7.01. Regulation FD Disclosure.

On September 1, 2021, One Medical issued a press release announcing the completion of the Merger and a press release announcing Ms. Tocio’s appointment as a director of One Medical. A copy of the press releases are furnished herewith as Exhibit 99.1 and 99.2, respectively, and incorporated herein by reference.

Attached as Exhibit 99.3 and incorporated herein by reference is a copy of an investor presentation dated September 1, 2021 prepared by One Medical.

The information contained in Exhibits 99.1, 99.2 and 99.3 is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, nor shall it be deemed incorporated by reference in any filing with the SEC made by One Medical, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01. Financial Statements and Exhibits.

(a)    Financial Statements of Businesses Acquired.

The consolidated financial statements of Iora required by this item and referenced in Exhibits 99.4 and 99.5 of this report were previously filed in the Registration Statement and are incorporated by reference herein.

(b)    Pro Forma Financial Information.

The pro forma financial statements required by this item and referenced in Exhibit 99.6 of this report were previously filed in the Registration Statement and are incorporated by reference herein.

(d) Exhibits.




Exhibit No.Description
23.1
99.1
99.2
99.3
99.4
99.5
99.6
104Cover Page Interactive Data File (formatted as Inline XBRL).



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 1LIFE HEALTHCARE, INC.
    
 By: /s/ Bjorn Thaler
Dated: September 1, 2021  Bjorn Thaler
   Chief Financial Officer


Document

Exhibit 23.1

CONSENT OF INDEPENDENT AUDITORS

We consent to the incorporation by reference in Registration Statement No. 333-254415 on Form S-3 and Registration Statement Nos. 333-254414 and 333-236247 on Form S-8 of 1Life Healthcare, Inc. of our report dated May 26, 2021, relating to the financial statements of Iora Health, Inc. incorporated in this Current Report on Form 8-K dated September 1, 2021 from Registration Statement No. 333-257720 on Form S-4.

/s/ Deloitte & Touche LLP
Boston, Massachusetts
September 1, 2021

Document

Exhibit 99.1

One Medical Completes Acquisition of Iora Health

SAN FRANCISCO – September 1, 2021 – One Medical (1Life Healthcare, Inc., Nasdaq: ONEM), a leading human-centered and technology-powered national primary care organization, today announced it has completed the acquisition of Iora Health, a human-centered, value-based primary care organization with built-for-purpose technology focused on serving Medicare populations.

“One Medical is now even better positioned to deliver better health, better care, and lower costs across every stage of life,” said Amir Dan Rubin, Chair & CEO of One Medical. “One Medical will extend its reach from children and adults to even more seniors, across 28 existing and announced combined geographies encompassing approximately 40% of the U.S. population, with a national potential addressable market of approximately $870 billion. One Medical’s demonstrated ability to delight and attract members, enable improved health outcomes, reduce the cost of care, and simultaneously deliver results for multiple key stakeholders will now be extended further in pursuit of our mission to transform healthcare.”

“One Medical and Iora have common mission-driven cultures, built-for-purpose technologies for our respective care models, and best-in-class teams, including salaried providers. In joining with One Medical, we can now deliver the best care and value to more people and in more geographies across the U.S.” said Rushika Fernandopulle, Co-Founder of Iora Health and Chief Innovation Officer of One Medical.

As of July 31, 2021, Iora took care of approximately 39,000 total patients, including 31,000 At-Risk members, 3,000 Consumer and Enterprise members, and 5,000 Other Patients.

Transaction Details

Pursuant to the merger agreement previously announced on June 7, 2021, One Medical issued or has reserved for issuance approximately 56 million shares in the transaction (including shares underlying options).

Financial Outlook

One Medical provides forward-looking guidance on membership count, revenue, care margin, and adjusted EBITDA. Care margin and adjusted EBITDA are non-GAAP measures. With the completion of the acquisition of Iora, One Medical is providing an update with regards to the third quarter 2021 and fiscal year 2021 outlook as set forth below. This update includes the contribution of Iora to One Medical’s financial results beginning September 1, 2021 to the third quarter 2021 and fiscal year 2021 outlook.

Three Months Ending
September 30, 2021
Twelve Months Ending
December 31, 2021
In $ millions, except membership dataLowHighLowHigh
Consumer & Enterprise
Members (1)

660,000

665,000

685,000

690,000
At-Risk Members (2)31,00032,00032,00033,000
Total Members (3)691,000697,000717,000723,000
One Medical Revenue$113$120$475$485
Iora Health Revenue$27$28$111$114
Total Revenue$140$148$586$599



Care Margin--$171$180
Adjusted EBITDA--$(40)$(45)

(1)    A Consumer & Enterprise member is a person who has registered with One Medical and has paid for membership for a period of at least one year or whose membership has been sponsored by an enterprise or other third party under an agreement having a term of at least one year. Consumer & Enterprise members do not include virtual-only One Medical Now users and any temporary users as part of One Medical’s community service. Consumer & Enterprise members provided above include a projected contribution of approximately 3,000 members from Iora.

(2)     An At-Risk member is a person for whom One Medical is financially responsible for managing the member’s healthcare costs, for example through Medicare Advantage or Medicare Direct Contracting.

(3)    Total Members exclude approximately 20,000 Other Patients as of July 31, 2021. “Other Patient” refers to a person who is neither a Consumer & Enterprise member nor an At-Risk member, and who has received digital or in-person care through One Medical over the last twelve months. Other Patients include a projected contribution of approximately 5,000 Other Patients from Iora.
at least one year or whose membership has bee
Membership data is rounded to thousands. Management has not reconciled forward-looking non-GAAP care margin and adjusted EBITDA to their most directly comparable GAAP measures of loss from operations and net loss, respectively. This is because we cannot predict with reasonable certainty and without unreasonable efforts the ultimate outcome of certain GAAP components of such reconciliations, including market-related assumptions that are not within our control, certain legal or advisory costs or others that may arise, without unreasonable effort. For these reasons, we are unable to assess the probable significance of the unavailable information, which could materially impact the amount of the future directly comparable GAAP measures. See below for additional important disclosures regarding our non-GAAP financial measures. Our definition of adjusted EBITDA has been revised from our previous reports of adjusted EBITDA to also adjust for certain legal or advisory costs prospectively from the first quarter of 2021, and adjust for acquisition and integration costs prospectively from the second quarter of 2021.

Non-GAAP Financial Measures

Care Margin: We define care margin as loss from operations excluding depreciation and amortization, stock-based compensation, general and administrative expense and sales and marketing expense. We consider care margin to be an important measure to monitor our performance, specific to the direct costs of delivering care. We believe this margin is useful to measure whether we are controlling third party medical and our direct expenses included in the provision of care sufficiently and whether we are effectively pricing our services.

Adjusted EBITDA: We define adjusted EBITDA as net income (loss) excluding interest income, interest expense, depreciation and amortization, stock-based compensation, change in the fair value of our redeemable convertible preferred stock warrant liability, provision for (benefit from) income taxes, certain legal or advisory costs, and acquisition and integration costs that the Company does not consider to be expenses incurred in the normal operation of the business. Such legal or advisory costs may include but are not limited to expenses with respect to evaluating potential business combinations, legal investigations, or settlements. Acquisition and integration costs include expenses incurred in connection with the closing and integration of acquisitions, which may vary significantly and are unique to each acquisition. We made this update to prospectively exclude from our presentation certain legal or advisory costs from the first quarter of 2021 and acquisition and integration costs from the second quarter of 2021, because amounts incurred in the prior periods were insignificant. We report adjusted EBITDA because it is an important measure upon which our management assesses and believes investors should assess



our operating performance. We consider adjusted EBITDA to be an important measure because it helps illustrate underlying trends in our business and our historical operating performance on a more consistent basis.
We believe that these non-GAAP financial measures, when taken together with the corresponding GAAP financial measures, provide meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations, or outlook. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. In addition, other companies, including companies in our industry, may calculate similarly-titled non-GAAP measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures as tools for comparison.

Available Information

One Medical intends to use its Company website (including its Investor Relations website) as well as its Facebook, Twitter and LinkedIn accounts as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Forward-Looking Statements

This press release contains forward-looking statements about us and our industry that involve substantial risks and uncertainties and are based on our beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations, financial condition, business strategy and plans and objectives of management for future operations and statements about One Medical's agreement to acquire Iora Health, Inc., are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” or “would,” or the negative of these words or other similar terms or expressions.
Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements represent our current beliefs, estimates and assumptions only as of the date of this press release and information contained in this press release should not be relied upon as representing our estimates as of any subsequent date. These statements, and related risks, uncertainties, factors and assumptions, include, but are not limited to: our ability to timely and successfully achieve the anticipated benefits and potential synergies of the transaction; the strength of the One Medical brand; member satisfaction with our services and support; the effects of the COVID-19 pandemic and related self-isolation and quarantine measures on our business, revenue, future growth and results of operations; anticipated membership growth and revenue potential from our members; our ability to retain members; our ability to successfully introduce and drive adoption of new products; changes in the pricing we offer our members; our relationships with our health network partners and enterprise clients and any changes to, accommodations in or terminations of our contracts with the health network partners or enterprise clients; our ability to improve cost of care and margins, including timing and expenses of new office openings and entry into new geographic markets; changes in laws or regulations; our involvement in existing and potential litigation, including medical malpractice claims and consumer class actions; any governmental investigations or inquiries, including those related to COVID-19 vaccine administration or challenges to our relationships with the One Medical PCs under the administrative services agreements; our strategic plan; our financial outlook; our focus areas for investment and our investments; announcements by us or our competitors of business or strategic developments; and our overall business trajectory. These risks are not exhaustive. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the



future. Further information on factors that could cause actual results to differ materially from the results anticipated by our forward-looking statements is included in the reports we have filed or will file with the Securities and Exchange Commission, including our Quarterly Report on Form 10-Q for the Quarter ended June 30, 2021. These filings, when available, are available on the investor relations section of our website at investor.onemedical.com and on the SEC’s website at www.sec.gov.

About One Medical

One Medical is a membership-based and technology-powered primary care platform with seamless digital health and inviting in-office care, convenient to where people work, shop, live, and click. Our vision is to delight millions of members with better health and better care while reducing costs. Our mission is to transform health care for all through our human-centered, technology-powered model. Headquartered in San Francisco, 1Life Healthcare, Inc. is the administrative and managerial services company for the affiliated One Medical physician owned professional corporations that deliver medical services in-office and virtually. 1Life and the One Medical entities do business under the “One Medical” brand.

About Iora Health

Iora Health is building a different kind of health system to deliver high impact relationship-based care. With a mission to restore humanity to health care and a goal to transform healthcare overall, Iora Health’s care model provides extraordinary service to patients to enable improved health outcomes while lowering overall health costs. Our patients enjoy the benefits of better access to care, office- and non-office-based encounters (e.g. phone, text messages, and email), an accessible and transparent medical record, and robust educational offerings. Our practices across the U.S. enjoy the benefits of smaller panel sizes, closer relationships with patients, and the opportunity to lead systemic change in health care delivery while working with a true team.

Media Contact:
Kristina Skinner, One Medical
Senior Director of External Communications
press@onemedical.com
650-743-5187

Investor Contact:
Bob East or Asher Dewhurst, Westwicke
onemedical@westwicke.com
443-223-0500

Document

Exhibit 99.2

One Medical Appoints Mary Ann Tocio to Board of Directors

SAN FRANCISCO, September 1, 2021 – One Medical (NASDAQ: ONEM), a leading national technology-powered primary care organization, today announced the appointment of Mary Ann Tocio to its board of directors. Ms. Tocio is the former President and Chief Operating Officer of Bright Horizons Family Solutions, and joins the board with over 30 years of leadership and operational experience. In addition, Ms. Tocio brings to One Medical extensive health care and medical management expertise, as well as substantial board experience across both private and public companies, including Iora Health.

“We are extremely delighted to welcome Mary Ann Tocio to our board of directors,” said Amir Dan Rubin, Chair & CEO of One Medical. “Mary Ann brings deep expertise in leading and scaling private and public companies, including in the human services field. Moreover, she brings tremendous insights with her clinical and healthcare leadership background, and having served on many public, private and non-profit boards, including on the boards of Iora and other healthcare organizations.”

“One Medical’s innovative approach to human-centered and technology-powered primary care is driving real impact by challenging the health care status quo,” said Tocio. “I am thrilled to join One Medical’s board at such a pivotal time in the organization’s journey and look forward to supporting its next phase.”

From 1992 to 2015, Ms. Tocio held several positions with Bright Horizons Family Solutions, an employer-sponsored child-care provider, most recently as its President and Chief Operating Officer. Prior to Bright Horizons, Ms. Tocio served as Senior Vice President of Operations for Wellesley Medical Management, Inc. (Health Stop and MedFirst), a provider of urgent care services. Ms. Tocio currently serves as a member of the board of directors of Bright Horizons Family Solutions, Burlington Stores, Inc., Telecare Corporation, and the Dana Farber Cancer Institute. In addition, she has also served on the board of Civitas Solutions and Mac-Gray Corporation, among others. Ms. Tocio holds a Masters in Business Administration from Simmons College School of Management and graduated from Lawrence Memorial School of Nursing.


About One Medical
One Medical is a membership-based and technology-powered primary care platform with seamless digital health and inviting in-office care, convenient to where people work, shop, live, and click. Our vision is to delight millions of members with better health and better care while reducing costs. Our mission is to transform health care for all through our human-centered, technology-powered model. Headquartered in San Francisco, 1Life Healthcare, Inc. is the administrative and managerial services company for the affiliated One Medical physician-owned professional corporations that deliver medical services in-office and virtually. 1Life and the One Medical entities do business under the “One Medical” brand.

Media Contact:
Kristina Skinner, One Medical
Senior Director of External Communications
press@onemedical.com
650-743-5187




Investor Contact:
Westwicke
Bob East or Asher Dewhurst
onemedical@westwicke.com
443-223-0500

ex993announcementdeck
1 + Transforming healthcare for all through a human-centered, technology-powered model at every stage of life September 2021


 
2 Forward-Looking Statements This presentation contains forward-looking statements which include, but are not limited to, statements regarding effects and anticipated benefits of the transaction between One Medical and Iora Health, Inc. (the “Merger”). These forward-looking statements are subject to the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. 1Life Healthcare’s expectations and beliefs regarding these matters may not materialize. Actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of uncertainties, risks, and changes in circumstances, including but not limited to risks and uncertainties related to: the ability of 1Life Healthcare to timely and successfully achieve the anticipated benefits and potential synergies of the Merger and the impact of health epidemics, including the COVID-19 pandemic, on the parties’ respective businesses and the actions the parties may take in response thereto. Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are included under the caption “Risk Factors” and elsewhere in 1Life Healthcare’s most recent filings with the SEC, including 1Life Healthcare’s Annual Report on Form 10-K for the year ended December 31, 2020 and any subsequent reports on Form 10-K, Form 10-Q or Form 8-K filed with the SEC from time to time and available at www.sec.gov. These documents can be accessed on the 1Life Healthcare web page at https://investor.onemedical.com and clicking on the link titled “Financial Information.” Any financial projections in this filing are forward-looking statements that are based on assumptions that are inherently subject to significant uncertainties and contingencies, many or which are beyond One Medical’s and Iora Health’s control. While all projections are necessarily speculative, One Medical and Iora Health believe that the preparation of prospective financial information involves increasingly higher levels of uncertainty the further out the projection extends from the date of preparation. The assumptions and estimates underlying the projected results are inherently uncertain and are subject to a wide variety of significant business, economic and competitive risks and uncertainties that could cause actual results to differ materially from those contained in the projections. The inclusion of projections in this presentation should not be regarded as an indication that One Medical and Iora Health, or their representatives, considered or consider the projections to be a reliable prediction of future events. The forward-looking statements included in this presentation are made only as of the date hereof. 1Life Healthcare assumes no obligation and does not intend to update these forward-looking statements, except as required by law. Disclaimer


 
3 Market and Industry Data This presentation also contains statistical data and estimates made by independent parties and by One Medical and Iora Health relating to market size and growth, as well as other data about industries and businesses. This data involves a number of assumptions and limitations, and neither One Medical nor Iora Health have independently verified the accuracy or completeness of this data. Neither One Medical, Iora Health nor any other person makes any representation as to the accuracy or completeness of such data or undertakes any obligation to update such data after the date of this presentation. In addition, projections, assumptions and estimates of future performance and the future performance of the markets in which One Medical and Iora Health operate are necessarily subject to a high degree of uncertainty and risk. Non-GAAP Financial Measures Financial measures included in forecasts provided to a board of directors or financial advisor in connection with a business combination transaction are excluded from the definition of “non-GAAP financial measures” under the rules of the SEC, and therefore the Iora Health projections, One Medical and Iora Health combined company projections, and estimated synergies included in this presentation are not subject to SEC rules regarding disclosures of non-GAAP financial measures, which would otherwise require a reconciliation of a non-GAAP financial measure to a GAAP financial measure. Reconciliations of non-GAAP financial measures were not provided to or relied upon by the One Medical board of directors, Iora Health, or One Medical's or Iora Health's respective financial advisors in connection with the Merger. Accordingly, no reconciliation of such financial measures is provided in this presentation. Disclaimer


 
4 Transaction Details Pro Forma Ownership(1) • One Medical shareholders: approximately 73% • Iora Health shareholders: approximately 27% Board and Management • Mary Ann Tocio joined the One Medical Board • Rushika Fernandopulle became One Medical’s Chief Innovation Officer • Announced on June 7, 2021 • Transaction closed on September 1, 2021Timing Merger Consideration • One Medical acquired 100% of Iora Health in an all stock transaction • Iora Health shareholders will receive approximately 56 million shares of One Medical common stock (1) Fully diluted


 
5 Strategic Rationale - One Medical + Iora Health • Membership-based relationships via employer sponsorships, direct-to-consumer, and attributed lives • Proprietary technology platforms support key stakeholders with digital health, inviting in-person care, employed salaried providers, and health network partnerships • Combination enables a lifetime relationship with members and enhances One Medical’s risk-taking capabilities Distinct models driving competitive advantages • Adds ~$700B in TAM, for combined TAM of ~$870 Billion across Commercial Primary Care and Total Medicare • ~40% of the U.S. population live in One Medical & Iora Health’s combined 28 geographic markets, creating a large membership growth opportunity Significant Enlargement of TAM Attractive Financial Profile and Opportunity • Accelerates One Medical’s standalone long-term annual revenue growth target of mid-20%+ to a pro forma CAGR of mid-30% from 2020 - 2030 • Expands One Medical’s existing capabilities of driving membership growth, member engagement, and total healthcare cost savings into Medicare • Opportunity to create significant value from revenue and cost synergies as well as capex savings • New populations and full-risk models • Expand in existing markets • Enter new markets Accelerates Our Growth Levers • Increase enterprise, consumer and Medicare members • Expand health network partnerships, including new payer relationships • Expand services offerings • Similar missions of transforming healthcare with human-centered and technology-powered models • Alignment of two primary care models serving key stakeholders – Consumers, Employers / Payers, Providers, Health Networks • Expands proven track records of delivering premier care, membership growth, population health, and cost management across Commercial and Medicare Transforming health care for all from within Creating a leading member-based, technology-powered primary care model for every stage of life


 
6 + Most Consumer Centered Healthcare Company(1) One Medical virtual + in-person primary care linked to 45% lower benefits costs(2) The Digital Health Startups Transforming The Future Of Healthcare(1) Combining two human-centered, technology-powered primary care platforms transforming healthcare for every stage of life A membership-based primary care platform with seamless digital health and inviting in-person care, convenient to where people work, shop, live and click A human-centric, value-based primary care group with built-for-purpose technology focused on serving Medicare patients (1) 2019. (2) JAMA, Network Open 2020, “Utilization and Cost of an Employer-Sponsored Comprehensive Primary Care Delivery Model.” Listed as one of the Most Innovative Companies(1) ● Longitudinal value-based care model largely serving Seniors in full-risk contracts ● Purpose-built technology ● Salaried-provider model ● Success in managing global capitation risk with proven cost savings ● Relationships with leading Medicare Advantage plans, Original Medicare, and new Medicare Direct Contracting program ● Member-based longitudinal relationships serving consumers and employers ● Purpose-built technology ● Salaried-provider model ● Proven cost savings of 8% - 45% to employers ● Clinical and digital integrations with premier health network partners ● Relationships with leading health plans


 
7 One Medical + Iora Health Aligned missions, models and cultures to transform healthcare Positions One Medical to advance the health of members across every stage of life Extends One Medical’s platform to deliver multi-modal care -- with 24/7 national digital health and in-person care -- across a combined 28 markets Accelerates the expansion of two high-growth organizations, with complementary cultures and models serving as a premier place to practice modernized healthcare Opportunity to create significant value, with an expected $350+ million in annual revenue synergies by 2025, ~$30 million in annual net cost synergies by 2025, and with ~$30 million in cumulative capex savings through 2025 Creates a premier national member-based, technology-powered primary care platform to deliver better health, better care, and lower costs seamlessly across Commercial and Medicare populations Expands potential market opportunity to ~$870 billion across Commercial and Medicare segments, including the new Medicare Direct Contracting program Enhances One Medical’s risk-taking capabilities and extends One Medical into full-risk Medicare reimbursement models Amplifies power of purpose-built technologies to deliver premier member experiences, population health, provider support, and value-based care across every stage of life


 
8 Current System Failing All Stakeholders 51% Dissatisfied with Consumer Experience Employer health benefit costs exceeding $21,000 for family coverage in 2020 (3) 29 Days wait to see a Family Physician (2) Dissatisfied with Consumer Experience (1)81% Burnout within Family Physicians in Primary Care (4)50% Constrained Access to Care (1) Prophet and GE Healthcare Camden Group Study 2016 (2) 2017 Merritt Hawkins Survey of Physician Appointment Wait Times (3) Kaiser Family Foundation Employer Health Benefits Survey 2020 Operate their primary care networks at a loss or are willing to (5)75% Pursue or are likely to pursue external relationships to build physician networks (5) 76% (4) Mayo Clinic Proceedings 2019 (5) American Hospital Association - Society for Healthcare Strategy & Market Development, 2019 (6) Centers for Medicare & Medicare Services Aging US population not served well, with medical spend for this group expected to increase 8% through 2028(6) Consumers Employers & Payers Providers Health Networks


 
9 One Medical Transforms Health Care for Key Stakeholders Consumers Employers & Payers Providers Health Networks 51% Dissatisfied with Consumer Experience 0-1 8-45% Net Promoter Score(1) Day wait for appointment Virtual care typically within minutes Employer savings (3) 33% Lower ER Costs (3) 100% Provider salary model for aligned incentives Fewer provider EHR tasks vs. industry (4) 100% Members with digital integration with network partners (6) 90 40%+90%ile Quality Scores (HEDIS Subset) (2) 100% Participation in leading health plan networks (5) (1) For the 12 months ended December 31, 2020. NPS measures willingness of consumers to recommend our services to others based on consumer surveys. We use NPS to gauge overall member satisfaction with providers and loyalty to our brand. NPS ranges from -100 to 100. (2) HEDIS stands for Healthcare Effectiveness Data and Information Set. This is a subset of those metrics related to primary care. (3) 8% savings per client case study, and 45% total and 33% ER savings published in JAMA Network Open Publication in 2020. (4) FY19 One Medical estimate vs. 2019 industry comparison - EHR Industry tasks, Health Affairs 38, No. 7. (5) As of December 31, 2020. (6) As of December 31 2020, 100% of members are covered under health network clinically integrated partnerships.


 
10 Iora Health: Similarly Transforms Health Care for Key Stakeholders Consumers Payers Providers Health Networks 51% Dissatisfied with Consumer Experience Net Promoter Score(1) 100% Provider salary model Higher provider engagement vs. industry (5) Participating in a growing number of Medicare Advantage health plans, as well as original Medicare, and new Medicare Direct Contracting Program 78 20% (1) Represents Iora Health’s net promoter score as administered by Press Ganey for 12 months ended 12/31/2020. NPS measures willingness of consumers to recommend services to others based on consumer surveys. NPS gauges overall patient satisfaction with providers and loyalty to brands. NPS ranges from -100 to 100. (2) For the 12 months ended 12/31/2020 Iora Health had ~19 average engagements per patient per year: ~16 digital and ~3 in-person (3) Medical Claims Expense Ratio defined as “Medical Claims Expense” / Revenue. Additional detail on slide “Iora Health: Business Model.” (4) Iora Health estimate compared to Medicare benchmark. (5) Per 2020 survey conducted by Culture Amp. (6) Centers for Medicare & Medicare Services. 40%+ Fewer ER Visits (4) ~8% Average Annual Medicare Market Growth 2019 - 2028(6)~40% Reduction in inpatient admissions (4) ~19x Avg. Patient Engagements Per Year(2) Track record of improving Medical Claims Expense Ratio with member tenure (27 Percentage Points improvement over 4 years)(3)


 
11 Iora Health: Membership Model Delivers for Seniors Vision To be the national platform for human-centric, value-based care, driving transformation of the healthcare industry and improving the lives of millions of seniors Leading national primary care platform with strong brand, proven ability to lower costs, and customer-centric focus Headquartered in Boston with over 600 employees, taking care of 39K patients including 31K At-Risk members, 3K Consumer and Enterprise members, and 5K Other Patients(1) Longitudinal value-based care membership model with 78 NPS(2) Participating in full-risk Medicare reimbursement models such as Medicare Advantage and Medicare Directing Contracting Value-based contracts with a growing number of top national payers (Aetna, Cigna, Humana, United, among others) Technology-enabled primary care with 19 average engagements per patient per year -- ~16 digital and ~3 in-person(3) (1) As of 7/31/2021. (2) Represents Iora Health’s net promoter score as administered by Press Ganey for 12 months ended 12/31/2020. NPS measures willingness of consumers to recommend services to others based on consumer surveys. NPS gauges overall patient satisfaction with providers and loyalty to brands. NPS ranges from -100 to 100. (3) For 12 months ended 12/31/2020.


 
12 Iora Health: Multi-Modal Membership Model High-touch, White Glove Service ● Care model based on developing trusted, longitudinal relationships ● 30 - 60 minute visits for full engagement with the care team ● Virtual visits from the comfort of a member’s home ● Supplemental services include yoga classes, wellness, and home visits ● Personal transportation to appointments and back home when appropriate Inviting Facilities ● Welcoming clinics in desirable, high-traffic retail settings ● Comfortable and inviting offices with a home-like feel ● National Iora Health standards and branding with local adaptations ● On-site labs enhance convenience Digital Engagement ● Purpose-built technology supports members in managing their health ● Members can access their care team and health information on any device ● Members can communicate by both email and messaging, along with convenient online appointment scheduling ● Members can see results, trends, clinic notes and records anytime, anywhere


 
13 Iora Health: The Medicare Market is Large and Growing ● A new value-based payment program enabling provider groups to take full risk on Original Medicare ● Program started in April 2021 to support the ~40M individuals with Original Medicare nationwide ● Iora is in the global direct contracting model across all of its markets, with the ability to expand into new geographies ● Meaningfully increases Iora Health’s TAM and growth opportunities New Direct Contracting Program ~80% of Iora Health’s patients are served in at-risk arrangements(3) Opportunity to enroll members into the Direct Contracting program over time Note: Direct Contracting Program went live in April 2021. (1) Centers for Medicare & Medicare Services (2) Congressional Budget Office (3) As of 7/31/21. ● $4.2 trillion in 2021 U.S. Healthcare spend, with over $900 billion spent across Medicare programs (1) ● Medicare population is projected to grow from ~62 million in 2020 to more than 70 million in 2025 (1) ● Medicare Advantage represented 39% of enrollees in 2020 and is projected to grow to 46% in 2025 (2) ● Seniors are ~17% of the U.S. population today and projected to grow to ~22% by 2050 (1) Medicare Market Overview (2) (2)


 
14 Aligned Membership-Driven Business Models 2021E Revenue (4)$318M Medical Claims Expense Ratio improvement over 4 Years (5)27 2017-2021E Revenue CAGR (4)53% 2021E Revenue (1)$480M Employer Medical Cost Savings (3)8%-45% July 31st, 2021 Total Patients (6) 2017-2021E Revenue CAGR (1)28% (1) 2021 Represents the mid-point of $475M - $485M revenue outlook provided on 9/1/2021. (2) Based on 12 months ended 12/31/2020. (3) 8% per client case study, and 45% published in JAMA Network Open Publication in 2020. (4) Iora Health 2021 revenue based on One Medical Management estimates as of 9/1/2021. (5) Medical Claims Expense Ratio defined as “Medical Claims Expense” / Revenue. Refer to slide titled “Iora Health: Business Model” for additional detail. (6) Total patients includes 31K at-risk members, 3K consumer and enterprise members, and 5K other patients + Avg. Patient Engagements Per Year (2)~19Avg. Member Engagements Per Year (2) Q2 2021 Total Members ~10 One Medical Iora Health 2017- Q2 2021 Patient CAGR 2017-Q2 2021 Membership CAGR %age points ~40% 621K ~27% 39K


 
15 Technology-Powered Proprietary Platforms One Medical Iora Health ~45% of members visit web/app monthly (1) 5x digital to in-person engagement(1) 50%+ completion of member health tasks (1) 100+ conditions with automated follow up (2)  40%+ reduction in provider EHR tasks (3) 95%+ generic Rx powered by algorithms (4) 100% of members within health network partnerships with digital interoperability (5) 45K+ average digital patient communications per month(1) 5x digital to in-person engagement(6) 150+ decision support elements across ~20 condition /demographic pathways(2) 1 in 10 new actively managed chronic conditions identified by population health analytics platform(1) 95%+ generic Rx powered by algorithms(1) 90% of hospital admissions/ER visits with real time notifications(1) (1) Data from December 31, 2020 last twelve months. (2) As of December 31, 2020. (3) FY'19 One Medical estimate vs 2019 industry comparison - EHR Industry tasks, Health Affairs 38, No. 7. (4) For common conditions. (5) As of December 31, 2020, all members are covered by health network partners. (6) In FY 2020, Iora Health had ~19 average engagements per patient per year: ~16 digital and ~3 in-person


 
16 Iora Health Accelerates Our Growth Strategy ✓ = strategies enhanced by Iora Health Opportunity to serve adjacent Commercial and Medicare populations across our combined 28 markets and beyond Expand Margin with Tech & Ops Leverage Expand Services, Populations, Channels Grow New Markets and Network Partnerships Grow Membership in Existing Markets ▪ Increase consumer awareness and brand recognition ▪ Continue to increase growth with employees and their dependents ▪ Increase engagement across all members ▪ Grow alongside our employer sponsors ▪ Expand into new Markets ▪ Enroll large multi-market employers ▪ Grow across footprints of existing health network partners ▪ Develop new health network partnerships in new markets ▪ Technology to further reduce in-office provider desktop medicine burdens and further advance virtual care efficiencies ▪ Longitudinal digital primary health care allowing for further member growth per footprint ▪ Increasing volume across existing investment base ▪ Services and program expansions (e.g. remote visits, pediatrics, behavioral health, COVID-19 care) ▪ New populations and risk models ▪ Expanded platform solutions through technology interoperability with potential channel partners and third-party offerings ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓


 
17One Medical Proprietary and Confidential New York San Diego Washington DC Chicago San Francisco Phoenix Seattle Los Angeles Portland Orange County Atlanta Boston Austin Raleigh-Durham* Milwaukee* National Digital Health and Expanding In-Person Care Houston* Columbus* 17 Tucson Denver Charlotte Cape Cod Hanover * One Medical announced new markets in 2021: Raleigh-Durham, Columbus, Houston, Kansas City, Huntsville, and Birmingham. Announced New markets in 2022: Miami, Dallas, and Milwaukee. Greensboro Complementary geographic presence creates an opportunity to leverage existing market footprint for further extensions. 28 Total Markets 10 22Standalone Iora Health Markets Standalone One Medical Announced Markets Miami* Kansas City* Huntsville* Birmingham* Dallas*


 
18 Transaction Significantly Expands Addressable Market U.S. Total ~$250B Opportunity to address ~$870 Billion of the $4.2 trillion(1) U.S. Healthcare market U.S. Total Top 50 MSAs ~$170B(2) ~$80B(3) (1) Centers for Medicare & Medicare Services (CMS). (2) Commercial segment represents estimated primary care spend for US population with commercial insurance per US Census 2019 American Community Survey and One Medical primary care market estimate. (3) One Medical markets and top 50 MSAs represent estimated primary care spend for those under 65 with commercial insurance per US Census 2019 American Community Survey. (4) Revenue PMPM before medical expenses used to calculate TAM; Enrollment data as of January 2020. Source: CMS; DRG. Assumes the following MA lives: ~2M lives in Iora Health’s current markets; ~8M lives in One Medical + Iora Health Markets; ~13M lives in Top 50 MSAs; ~24M lives in Total U.S. (5) Note: Direct Contracting Program went live in April 2021. Direct Contracting model represents potential 30x or more annual revenue opportunity for aligned lives for full-risk global models. Assumes the following Original Medicare Lives: ~2M in Iora Health’s current markets; ~11M in One Medical + Iora Health markets; ~17M in Top 50 MSAs; ~38M in Total U.S. Source: CMS. Note that Direct Contracting eligibility requirements could impact the number of beneficiaries eligible for alignment with Iora Health. One Medical + Iora Health Announced Markets ~$80B One Medical + Iora Health Announced Markets ~$55B(3) ~$15B Current Iora Health markets ~$50B(3) One Medical’s 22 Announced Markets Top 50 MSAs ~$20B Current Iora Health markets ~$140B One Medical + Iora Health Announced Markets Total TAM ~$870 Billion ~$125B One Medical TAM Commercial Primary Care Iora Health TAM Medicare Advantage Market(4) New: Iora Health TAM Direct Contracting Opportunity(5) ~$205B Top 50 MSAs ~$450B U.S. Total


 
19 (1) One Medical revenue growth based on 2020 reported financials and the mid-point of 2021 revenue outlook for One Medical provided on 9/1/2021 of $475M - $485M for FY21. Iora Health’s 2020 financials are audited as of December 31, 2020. Revenue based on ASC 606. Iora Health 2021 revenue based on One Medical Management estimates as of 9/1/2021. (2) One Medical market data as of 8/31/2021. 2020 revenues based on reported financials. ONEM 2021 revenue based on mid-point of 2021 revenue outlook provided on 9/1/2021 of $475M - $485M. (3) Iora Health multiple reflects implied total transaction value of $1.4Bn. Iora Health’s 2020 financials are audited as of December 31, 2020. Revenue based on ASC 606. Iora Health 2021 revenue based on One Medical Management estimates as of 9/1/2021. Attractive Valuation and Growth Profile 2020 2020 2021E2021E 9.0x AV / Revenue (2)(3) 26% 49% 2021E Revenue Growth YoY(1) 7.1x 4.3x 6.5x


 
20 Summary 2021 Forecast (1) 2021 Represents the mid-point of 2021 outlook provided on 8/4/2021: FY21 revenue of $475M - $485M, FY21 care margin of $185M - $195M, FY21 adjusted EBITDA of approximately breakeven. (2) Combined company includes Iora Health beginning on 9/1/2021; Represents the mid-point of 2021 outlook provided on 9/1/2021: FY21 revenue of $586M - $599M, FY21 care margin of $171 - $180M, FY21 adjusted EBITDA of $(40M) - $(45M). One Medical 2020 2021E(1) Total Revenue % year-over-year $380M $480M 26% Total Care Margin $145M $190M % of revenue 38% 40% Total Adj. EBITDA ($14M) $0M % of revenue (4%) 0% One Medical Plus Iora beginning 9/1/2021 2020 2021E(2) Total Revenue % year-over-year N/A $592.5M 56% Total Care Margin N/A $175.5M % of revenue 30% Total Adj. EBITDA N/A ($42.5M) % of revenue (7%)


 
21 2017 Member Cohort 2018 Member Cohort 2019 Member Cohort 2020 Member Cohort Historical Medical Claims Expense Ratio Risk-based membership economics allow Iora Health to capture value created through improved care quality and outcomes ● Membership-driven business model ● Value-based contracts create predictable and visible per-member revenue streams ● Revenue Per Member can improve over time through quality-improvement initiatives ● Medical Claims Expense1 can improve over time from primary care engagement and population health management, improving member health and satisfaction, while reducing the need for avoidable and costly care, thus lowering total costs for seniors, plan sponsors, and CMS ● Improvements in Medical Claims Expense Ratio create a flywheel for future growth investment as well as long-term profitability Iora Health: Business Model 27 percentage points improvement over 4 years Demonstrated track record of improving medical claims expense ratio with member tenure Year 1 Year 2 Year 3 Year 4 (1) Medical Claims Expense represents costs paid to third-parties for care delivered outside of Iora Health’s primary care Medical Claims Expense Revenue Medical Claims Expense Ratio =


 
22 Iora Health: Attractive Mature Risk-Based Economics Target Risk-Based Membership Economics (1) Cost of care excludes depreciation and amortization and primarily includes provider and support employee-related costs for both in-office and virtual care, occupancy costs, medical supplies, insurance and other operating costs ● One Medical & Iora Health can build upon their track records of lowering healthcare costs across different patient populations to further improve Medical Claims Expense and Cost of Care1 over time ● Optimizing Care Margin and SG&A by leveraging combined technology, people, real estate, and go-to-market strategies ● Targeting long-term Adjusted EBITDA of 17%+ of revenue per member 17%+ Long-term Adj. EBITDA per member Revenue Medical Claims Expense Cost of Care1 SG&A Adj. EBITDA Opportunity to leverage One Medical’s technology to deliver attractive, long-term economics across Medicare patients Medical Claims Expense Revenue Medical Claims Expense Ratio =


 
23 Revenue synergies through accelerated membership growth ● Opportunity to serve parents and grandparents of One Medical’s 621K members(1) ● Expand into Medicare services in One Medical markets ● Expand into Commercial services in Iora Health Markets ● Seamless age-in and extend lifetime relationship with members as they transition from Commercial to Medicare ● Leverage brand recognition to accelerate membership growth in overlapping markets ● Leverage Health Network Relationships ● Further potential additional synergies in new markets and services $350M+ annual revenue synergies by 2025 Synergy Opportunities Reduce Medical Costs Engage Members Drive Membership Synergies enabled by One Medical’s strengths (1) Q2 2021 Total Members


 
24 Synergy Opportunities Enhanced cost savings for improved profitability ● Efficiencies across virtual and in-person care delivery, space design, staffing, processes and technology platforms ● Increased leverage across existing investment base ● Combined business models for greater scale ● Reciprocal access across offices to optimize combined physical footprint ~$30M annual net cost synergies by 2025 ~$30M cumulative Capex savings through 2025 Adj. EBITDA Breakeven Around Year End 2024


 
25 Long-Term Projections (Non-GAAP) Mid-20%+ Long-term Annual Revenue Growth 20% Long-term Adjusted EBITDA Margin Target +One Medical Long-Term Goals 17%+ Long-term Adjusted EBITDA Margin Target Mid-30% 2020 - 2030 Revenue CAGR


 
26 One Medical + Iora Health Aligned missions, models and cultures to transform healthcare Positions One Medical to advance the health of members across every stage of life Extends One Medical’s platform to deliver multi-modal care -- with 24/7 national digital health and in-person care -- across a combined 28 markets Accelerates the expansion of two high-growth organizations, with complementary cultures and models serving as a premier place to practice modernized healthcare Opportunity to create significant value, with an expected $350+ million in annual revenue synergies by 2025, ~$30 million in annual net cost synergies by 2025, and with ~$30 million in cumulative capex savings through 2025 Creates a premier national member-based, technology-powered primary care platform to deliver better health, better care, and lower costs seamlessly across Commercial and Medicare populations Expands potential market opportunity to ~$870 billion across Commercial and Medicare segments, including the new Medicare Direct Contracting program Enhances One Medical’s risk-taking capabilities and extends One Medical into full-risk Medicare reimbursement models Amplifies power of purpose-built technologies to deliver premier member experiences, population health, provider support, and value-based care across every stage of life


 
27 Transforming healthcare for all through a human-centered, technology-powered model to deliver better health, better care, and better value at every stage of life +


 
28 Thank You